company
Par Health USA, LLC
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-06-24Par Health USA, LLC — Class II recall: Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Ca…
Frequently asked questions
- How many FDA warning letters has Par Health USA, LLC received?
- Argus HQ has not recorded an FDA warning letter for Par Health USA, LLC in our current dataset.
- What FDA recalls has Par Health USA, LLC issued?
- Argus HQ has recorded 1 FDA recall tied to Par Health USA, LLC.
- Is Par Health USA, LLC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Par Health USA, LLC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

